Rosuvastatin vs Placebo in the prevention of CV events: JUPITER Study
- Dr. Sishir Kumar
- Sep 9
- 2 min read
Updated: Sep 10
Ridker et al conducted the JUPITER (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) study to evaluate the efficacy of Rosuvastatin among patients with low levels of LDL-C and elevated hs-CRP in the prevention of cardiovascular events (1).
Study Summary
About the Author
Dr. Sishir Kumar is a medical communications professional with a research doctorate (PhD) in oncology research and drug discovery. He has published 13 articles in reputed international journals like Drug Discovery Today, Nanomedicine, Medicinal Research Reviews, Wiley - Food Bioengineering, Frontiers in Nutrition, etc. His interest and expertise are in publication writing and the development of medico-marketing materials in different therapeutic areas such as Cardiology, Oncology, and Diabetes, etc., He is passionate and keen on the development of effective medical communication materials for a wide variety of clinical research projects.
Abbreviations
JUPITER: Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin; CVD: Cardiovascular disease; LDL-C: Low-density lipoprotein-cholesterol; hsCRP: High-sensitivity C-reactive protein; MI: myocardial infarction; CABG: Coronary artery bypass graft surgery; PTCA: Percutaneous transluminal coronary angioplasty; UA: Unstable Angina;
Reference
Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207.
Disclaimer
The matter published on this platform has been developed by independent medical writers from various healthcare backgrounds including members of MedWriters Alumni Network. Although great care has been taken in compiling and checking the information, the authors, Rxnews team and its partners or agents, and sponsors shall not be responsible or in any way liable for any errors, omissions, or inaccuracies in this blog article whether arising from negligence or otherwise, however or for any consequences arising therefrom. The inclusion and exclusion of any product do not mention that the publisher advocates or rejects its use generally or in any particular field or field. For any complaints or feedback please write to content@rxnews.in
Comments